Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.

Bhattacharya D, Yusuf N.

Int J Breast Cancer. 2012;2012:716564. doi: 10.1155/2012/716564. Epub 2011 Nov 9.

2.

Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X.

J Exp Clin Cancer Res. 2010 Jul 10;29:92. doi: 10.1186/1756-9966-29-92.

3.

Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines.

Huang Y, Cai B, Xu M, Qiu Z, Tao Y, Zhang Y, Wang J, Xu Y, Zhou Y, Yang J, Han X, Gao Q.

PLoS One. 2012;7(7):e38890. doi: 10.1371/journal.pone.0038890. Epub 2012 Jul 16.

4.

Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.

Basith S, Manavalan B, Yoo TH, Kim SG, Choi S.

Arch Pharm Res. 2012 Aug;35(8):1297-316. doi: 10.1007/s12272-012-0802-7. Epub 2012 Sep 1. Review.

PMID:
22941474
5.

Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer.

Amarante MK, de Oliveira KB, Guembarovski RL, da Silva do Amaral Herrera AC, Guembarovski AL, Sobrinho WJ, Voltarelli JC, Watanabe MA.

Mol Biol Rep. 2012 Dec;39(12):11087-92. doi: 10.1007/s11033-012-2013-1. Epub 2012 Oct 11.

PMID:
23053995
6.

Toll-Like Receptors (TLRs): The Role in Tumor Progression.

Shcheblyakov DV, Logunov DY, Tukhvatulin AI, Shmarov MM, Naroditsky BS, Gintsburg AL.

Acta Naturae. 2010 Jul;2(3):21-9.

7.

Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma.

Szczepański M, Stelmachowska M, Stryczyński L, Golusiński W, Samara H, Mozer-Lisewska I, Zeromski J.

Eur Arch Otorhinolaryngol. 2007 May;264(5):525-30. Epub 2006 Dec 13.

PMID:
17165086
8.

Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.

Yu L, Wang L, Chen S.

Biochim Biophys Acta. 2013 Apr;1835(2):144-54. doi: 10.1016/j.bbcan.2012.10.006. Epub 2012 Dec 8. Review.

PMID:
23232186
9.

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

González-Reyes S, Marín L, González L, González LO, del Casar JM, Lamelas ML, González-Quintana JM, Vizoso FJ.

BMC Cancer. 2010 Dec 3;10:665. doi: 10.1186/1471-2407-10-665.

10.

Toll-like receptors, tissue injury, and tumourigenesis.

Ioannou S, Voulgarelis M.

Mediators Inflamm. 2010;2010. pii: 581837. doi: 10.1155/2010/581837. Epub 2010 Sep 14. Review.

11.

The inflammatory chemokines CCL2 and CCL5 in breast cancer.

Soria G, Ben-Baruch A.

Cancer Lett. 2008 Aug 28;267(2):271-85. doi: 10.1016/j.canlet.2008.03.018. Epub 2008 Apr 24. Review.

PMID:
18439751
12.

Toll-like receptor expression in normal ovary and ovarian tumors.

Zhou M, McFarland-Mancini MM, Funk HM, Husseinzadeh N, Mounajjed T, Drew AF.

Cancer Immunol Immunother. 2009 Sep;58(9):1375-85. doi: 10.1007/s00262-008-0650-y. Epub 2009 Jan 31.

PMID:
19184006
13.
14.

Toll-like receptors and cancer, particularly oral squamous cell carcinoma.

Rich AM, Hussaini HM, Parachuru VP, Seymour GJ.

Front Immunol. 2014 Sep 24;5:464. doi: 10.3389/fimmu.2014.00464. eCollection 2014. Review.

15.

TLRs: linking inflammation and breast cancer.

Bhatelia K, Singh K, Singh R.

Cell Signal. 2014 Nov;26(11):2350-7. doi: 10.1016/j.cellsig.2014.07.035. Epub 2014 Aug 3. Review.

PMID:
25093807
16.

Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.

Szczepański M, Szyfter W, Jenek R, Wróbel M, Lisewska IM, Zeromski J.

Eur Arch Otorhinolaryngol. 2006 Jul;263(7):603-7. Epub 2006 Mar 15.

PMID:
16538507
17.

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies.

Muccioli M, Benencia F.

Front Immunol. 2014 Jul 22;5:341. doi: 10.3389/fimmu.2014.00341. eCollection 2014. Review.

19.

Important aspects of Toll-like receptors, ligands and their signaling pathways.

Chang ZL.

Inflamm Res. 2010 Oct;59(10):791-808. doi: 10.1007/s00011-010-0208-2. Epub 2010 Jul 1. Review.

PMID:
20593217
20.

TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance.

He W, Liu Q, Wang L, Chen W, Li N, Cao X.

Mol Immunol. 2007 Apr;44(11):2850-9. Epub 2007 Feb 27.

PMID:
17328955
Items per page

Supplemental Content

Write to the Help Desk